Kolberg-Liedtke C, Feuerhake F, Garke M, Christgen M, et al. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial. Breast Cancer Res 2022;24:58.
PMID: 36056374